Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

View:
Post by northernwinds on Jun 25, 2010 5:08pm

Credible!

Yes! most wall street advisers are definitely worth listening to! They have proven themselves to be worth their weight in gold over the last decade! NOT  When an advisers commision is based on % of  return for a client, I will garner a little respect for them. More often than not advisers have pushed what evers going with little Due diligence. Why are you on this board Mac B? Tell me something of substance, the chicken little routine anoys the hell out me! You offer nothing but cohertion to sell,  sell and leave! The rest of us hold a tangible interest in ISA. Your either in or out, and right now we have absolutly nothing to go on! So quit making up stories, regarless of what your motives are.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities